Related Experiment Videos
Tissue microarrays (TMAs) for high-throughput molecular pathology research
A Nocito1, J Kononen, O P Kallioniemi
1Institute of Pathology, University of Basel, Schönbeinstrasse 40, 4003 Basel, Switzerland.
International Journal of Cancer
|October 23, 2001
Summary
Tissue microarrays (TMAs) enable high-throughput molecular analysis of thousands of tumors. This technology accelerates the evaluation of potential cancer genes and biomarker characterization for clinical applications.
Area of Science:
- Oncology
- Molecular Pathology
- Biotechnology
Background:
- Increasing number of genes implicated in cancer biology.
- Evaluating clinical significance of novel cancer genes requires analyzing numerous primary tumors.
- Traditional methods are time-consuming and deplete tissue resources.
Purpose of the Study:
- To develop a high-throughput tissue analysis method.
- To enable rapid molecular profiling of a large number of tumors.
- To accelerate the clinical application of cancer research findings.
Main Methods:
- Development and application of "tissue chip" technology, known as tissue microarray (TMA).
- Arraying samples from up to 1,000 tumors into a single paraffin block.
- Performing simultaneous in situ analyses on DNA, RNA, or protein levels from TMA sections.
Main Results:
- TMAs facilitate high-throughput molecular analysis of thousands of tumors within hours.
- Arrayed tissue specimens are highly representative of their original donor tissues.
- Multiple TMA types (multi-tumor, progression, prognostic) enable comprehensive biomarker characterization.
Conclusions:
- TMAs significantly enhance the efficiency of molecular pathology analyses.
- This technology accelerates the validation of potential cancer genes and biomarkers.
- TMAs are expected to expedite the translation of basic research into clinical practice.